Oncology & Micropigmentation
Rejuvenation of the Brows and Eyes after cancer diagnosis.
The diagnosis of cancer is enough to shatter anyone’s world and can be a huge shock to the system upon hearing those words. One of the things cancer patients feel they need the most is normalcy! In a world where you feel is now upside down and moving a little too slow or having almost stopped, normalcy is the one thing that can keep you on track and help you get through day to day life.
Along with a cancer diagnosis comes change, change to every-day life and change to your appearance. Here at DC Micro we can minimise the change in appearance that comes with cancer treatment, such as losing hair, eyebrows and eyelashes etc. Many clients remark at how different they feel when they look in the mirror and no longer see eyebrows and eyelashes and how they can feel they look ‘unwell’ when in fact they can feel quite fine.
Within the specialty of oncology micropigmentation, the most requested application is the optical rejuvenation of the eyebrows and eyeliner. These treatments can be applied to patients of both sexes, any age and have been diagnosed with any type of cancer, which is being treated with chemotherapy.
With chemotherapy treatments clients can experience loss of hair from the head and hair from the eyelashes and eyebrows. With the optical rejuvenation of the eyebrows and eye definition, micropigmentation can ensure that the clients face keep the lines that give structure and balance to the facial contours. Thanks to permanent makeup the client can maintain an appearance of ‘aesthetic normalcy’ during chemotherapy, avoiding awkward questions, achieving intimacy and self-esteem, thereby improving their confidence and ability to confront the illness for a successful treatment.
Micropigmentation techniques should be informed to the client by the first stage of their cancer diagnosis as the techniques should always be applied before the start of chemotherapy treatment, ensuring the micropigmentation is in place for when chemotherapy has finished to recreate lost eyebrows and eyelashes.
Micropigmentation used to create eyebrows and eyeliner requires the application of many techniques using several different needles and shades. This treatment must only be performed by highly experienced professionals who have acquired great skill, precision and knowledge. Below we show a step by step guideline on how the treatment will be carried out.
The design will be transferred using brow mapping and reference points that will mark the outline for the completion of the treatment. We can then build the brow to mimic the look of realistic hair or if preferred a powder brow to mimic the look of light makeup application for that little bit more definition.
The eyeliner design will be applied to create a subtle definition to the eyes that would naturally be given from eyelashes. A small subtle eyeliner will help define the eyes and create a focal point for people to communicate with you effectively. We can apply eyeliner to both the upper and lower lash line to create a natural look that clients agree makes them look ‘healthier’ during their treatment
We recommend that you book your micropigmentation treatments soon after receiving your cancer diagnosis. There can sometimes be a short period of time from diagnosis to cancer treatment, we recommend the treatments be done in this time. This is to ensure you receive the best healed results before starting treatment, as cancer therapy can affect the immune system and the body’s natural healing responses. You would usually need a second session 4 weeks later, however because treatment will have assumedly already started, we then recommend for the second session to be performed 6 months after the end of cancer treatment
We ask all clients to follow all advice from their oncology team and request that you have approval from your oncologist to go ahead with treatment. We request that we receive a written consent letter from your oncologist to present to us at your first treatment. For insurance purposes we are unable to carry out the treatment without oncologist consent